Viewing Study NCT05053802


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2025-12-26 @ 2:30 AM
Study NCT ID: NCT05053802
Status: RECRUITING
Last Update Posted: 2021-09-23
First Post: 2021-09-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: L20-349
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators